维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="Lagarce F"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Oxaliplatin loaded PLAGA microspheres: design of specific release profiles 显示文摘	LAGARCE F CRUAUD O DEUSCtlEL C	2002	lnt J Pharm2002，242，12：	1
2	Baelofen-loaded micro- spheres: preparation and effieacy testing in a new rabbit model 显示文摘	Lagarce F Renaud P Faisant N	2005	Eur J Pharm Biopharm2005，59，3：	1
3	Oxaliplatin loaded PLAGA microspheres : design of specific release profiles 显示文摘	Lagarce F Cruaud O Deuschel C	2002	Int J Pharm2002，242，12：	1
4	Oral fondaparinux:use of lipid nanocapsules nanocarriers and in vivo pharmacokineticstudy 显示文摘	Ramadan A Lagarce F Tessier-Marteau A	2011	Int J Nanomedicine2011，6，：	1
5	Development and characterization of interleukin-18-1oaded biodegradable mierospheres显示文摘	Lagarce F Garcion E Faisant N	2006	In J Pharm2006，314，2：	1
6	The gastrointestinal stability of lipid nanocapsules显示文摘	Roger E Lagarce F Benoit JP	2009	Int J Pharm2009，379，2：	1
7	Oxaliplatin loaded PLAGA microspheres : design of specific release profiles 显示文摘	Lagarce F Cruaud O Deuschel C	2002	Int J Pharm2002，242，12：	1
8	Development and charac- terization of a novel lipid nanocapsule formulation of SN38 for oral administration显示文摘	Roger E Lagarce F Benoit JP	2011	European Journal of Ph- armaceutics & Biopharmaceutics2011，79，1：	1
9	Oxaliplatin loaded PLAGA microspheres: design of specific release profiles显示文摘	Lagarce F Cruaud O Deuschel C	2002	Int J Pharrn2002，242，12：	1
10	Development and characterization of interleukin-18-loaded biodegradable microspheres 显示文摘	LAGARCE F GARCION E FAISANT N	2006	International Journal of Pharmaceutics2006，314，：	1
11	Oxaliplatin loaded PLAGA microspheres:design of specific release profiles显示文摘	LAGARCE F CRUAUD O DEUSCHEL C	2002	Int J Pharm2002，242，12：	1
12	Baclofen-loadedmicrospheres:Preparation and efficacy testing in a new rab-bit model显示文摘	Lagarce F Renaud P Faisant N	2005	Eur J Pharm Biopharm2005，59，3：	1
13	Oxaliplatin loaded PLAGA microspheres: design of specific release profiles 显示文摘	LAGARCE F CRUAUD O DEUSCHEL C	2002	lnt J Pharm2002，242，12：	1
14	Development and characteri-zation of a novel lipid nanocapsule formulation of SN38 for oral administration显示文摘	Roger E Lagarce F Benoit J P	2011	Eur J Pharm Biopharm2011，79，1：	1
15	Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery 显示文摘	Roger E Lagarce F Garcion E	2010	Nanomedicine2010，5，2：	1
16	The adaptation of lipid nanocapsule formulations for blood administra- tion in animals显示文摘	Hureauxa J Lagarce F Gagnadoux F	2009	Int J Pharm2009，379，：	1
17	Biopharmaceutical parameters to consider in order to alter the fate of xano- carriers after oral delivery 显示文摘	Roger E Lagarce F Garcion E	2010	Nanomedicine (Lond)2010，5，2：	1
18	Development and characteriza- tion of a novel lipid nanocapsule formulation of Sn38 for oral administration 显示文摘	Roger E Lagarce F Benoit JP	2011	Eur J Pharm Biopharm2011，79，1：	1
19	Development and char- aeterization of a novel lipid nanocapsule formulation of Sn38 for oral administration显示文摘	ROGER E LAGARCE F JEAN-PIERRE B	2011	European Journal of Pharmaceutics and Biopharma- ceutics2011，79，1：	1
20	Lipid nanocarriers improve paclitaxel transport throughout human intestinal epi- thelial cells by using vesicle-mediated transcytosis显示文摘	ROGER E LAGARCE F GARCION E	2009	J Control Release2009，140，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示